Kory Wentworth

Chief Financial Officer at Entrada Therapeutics

Speaker

Kory Wentworth is Chief Financial Officer and Treasurer of Entrada Therapeutics and responsible for its capital formation strategy, financial planning, reporting and information technology for the company. Kory joined Entrada in 2020 and brings over 15 years of experience in the biotechnology sector with a passion for developing successful teams known for integrity and delivering high quality results and insightful analysis. Kory has led both commercial and clinical stage companies through high growth, global product launches, operational scale, financial strategies and fundraising. Kory was previously Vice President of Finance and Treasurer, and Principal Accounting Officer, at bluebird bio, Inc. and held senior finance positions at Alexion Pharmaceuticals and consulting roles in PricewaterhouseCoopers LLP’s assurance and business advisory practice. Kory has a BS in Accounting from Susquehanna University and is a Certified Public Accountant.